Thus, Nuf mice with a gain-of-function CaSR mutation exhibited impaired glucose tolerance, which was associated with reduced pancreatic islet mass and hypoinsulinemia as well as a lack of glucose-mediated suppression of glucagon secretion. Here, CASR is linked to Impaired glucose tolerance.